How much is Contraline worth in 2026?

Contraline has a current valuation of $60.0M based on their Later Stage VC round and secondary market data.

How much funding has Contraline raised?

Contraline has raised $41.7M in total funding across 2 funding rounds.

Contraline

Drug DiscoveryWebsite

Contraline valuation and funding history | Last updated: February 1, 2025 | 2 funding rounds

Current Valuation

$60.0M

As of February 1, 2025

Total Funding Raised

$41.7M

Across 2 rounds

Last Round

Later Stage VC

$500.0K

Last Funding

Feb 2025

Funding date

Capital Efficiency

1.44x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 5, 2022	Later Stage VC	$7.2M	N/A	-
October 20, 2021	Later Stage VC (Series A1)	$16.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Contraline is currently valued at $60.0M as of February 1, 2025. The company has raised a total of $41.7M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.44x, Contraline has achieved a valuation that is 1.44 times the total capital raised.

Track Contraline Valuation Updates

Get notified when Contraline raises new funding or valuation changes

Explore More Data

Detailed analysis for Contraline

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Contraline's valuation history, funding rounds, and growth metrics.

No credit card required

What is Contraline Worth in 2026?

Contraline is a leading private company in the Drug Discovery sector. Track Contraline's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Contraline Valuation is Determined

Private company valuations like Contraline's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.